Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3212 A D V A M E D 2 0 1 6 A N N U A L R E P O R T u I N T E R N AT I O N A L LOWERING BARRIERS IN GLOBAL MARKETS AdvaMed’s Global Strategy and Analysis department works to open markets for medical technology companies by advocating for trade, regulatory and reimbursement practices that are fair, transparent and predictable worldwide. Our team of international policy experts works with U.S. and foreign health care and government officials, and organizations like the World Health Organization, the World Trade Organization, the Asia-Pacific Economic Cooperation forum, and other international medical technology associations, to help ensure policies that facilitate worldwide patient access to life-changing innovations. CHINA – In 2016, AdvaMed’s China Board held its provincial meeting in Kunming at the invitation of the Yunnan governor. Over 200 people participated, including 32 mayors and 120 local and central government officials, providing an excellent platform to develop relationships and exchange views on how best to spur medtech innovation. Successful AdvaMed advocacy led to key commitments from China at a subsequent meeting of the Joint Commission on Commerce and Trade. Most significantly, China agreed to develop a unique device identification system based largely on the U.S. system, saving our industry an estimated $1 billion in costs. China also committed to de-link indigenous innovation policies from government procurement preferences, strengthen government oversight of procurement activities, and treat foreign products fairly. The Association also worked to implement a China-specific code of ethics in 2016, and achieved official sign-on from the China medical technology association CAMDI to help broaden the reach and impact of the code. Bringing Innovation to Patient Care Worldwide AdvaMed is the world’s leading medical technology trade association. Headquartered in the U.S., AdvaMed represents manufacturers of medical devices and diagnostics all over the world – from the largest to the smallest companies – and has a global presence that includes China, Japan, India, Brazil and Europe. AdvaMed seeks to advance policies that support investment, innovation and patient access to medical technology, to help achieve healthier lives and economies in China and around the world. • Decades of experience in China, some more than a century. • Approximately 60,000 employees, with thousands in R&D. • Nearly 300 offices across the country. • Over 8 billion RMB in fixed assets, 30% through joint ventures and over 40% through controlling investments in local firms, nearly all belonging to a Chinese health care association. • R&D collaborations with Chinese academic institutions. • Medical education delivered to about 100,000 health care professionals each year, with nearly 100 customer training centers around the country. • Tens of millions RMB in annual donations to Chinese charities. AdvaMed Member Contributions in China Many AdvaMed members have made substantial investments in China, including establishment of research and manufacturing facilities and other efforts that contribute to China’s growth. Survey results from just two dozen AdvaMed members reflect: Learn more about AdvaMed at: www.advamed.org, or Contact our China office at: AdvaMed China C-01, 18F Taiping Finance Tower No. 488, Middle Yincheng Road, Pudong 200120 Shanghai Phone: 86 21 6156 1504 Wang Lanming, director general of the China FDA’s department for medical device evaluation (center left, adjacent AdvaMed’s Ralph Ives), and other senior CFDA officials, visit AdvaMed in October to discuss China regulatory priorities.